CDC Delays Infant Hepatitis B Vaccine Recommendation, Studies Warn of Hundreds of New Infections

📰 Article

The U.S. Centers for Disease Control and Prevention (CDC) has delayed its recommendation for newborn hepatitis B vaccination, a decision that has sparked widespread concern among medical professionals and public health experts. According to The Washington Post, multiple studies warn that this move could result in hundreds of new hepatitis B infections annually across the United States.

Hepatitis B virus (HBV) is a serious liver infection that can be transmitted from mother to child during birth. Since 1991, the United States has recommended that all newborns receive their first dose of the hepatitis B vaccine within 24 hours of birth—a policy widely recognized as one of the most effective public health measures for preventing HBV infection.

According to reporting by The Hill, modeling studies suggest that halting the recommendation for newborn hepatitis B vaccination could lead to hundreds of additional infections each year. Medical experts note that approximately 90% of infants infected with hepatitis B at birth will develop chronic infection, which can lead to severe complications including cirrhosis and liver cancer.

This delay follows a recent decision by the CDC’s advisory committee to abandon its recommendation for COVID-19 vaccination, stating that it should be a personal choice. This series of policy shifts has raised questions about the independence and scientific basis of CDC vaccine guidance.

The American Academy of Pediatrics (AAP) and other professional medical organizations have strongly supported the newborn hepatitis B vaccination policy. They argue that any delay or reversal of this recommendation would disproportionately affect the most vulnerable population—newborns.

Public health experts emphasize that any changes to hepatitis B vaccination policy should be grounded in robust scientific evidence and epidemiological data, rather than political considerations. They urge policymakers to carefully consider the long-term public health consequences of this decision.

Sources: The Washington Post / The Hill